KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Depreciation and Depletion (2016 - 2024)

Historic Depreciation and Depletion for Petmed Express (PETS) over the last 15 years, with Q1 2024 value amounting to -$61000.0.

  • Petmed Express' Depreciation and Depletion fell 10643.46% to -$61000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $5.1 million, marking a year-over-year increase of 4571.43%. This contributed to the annual value of $5.1 million for FY2025, which is 0.0% changed from last year.
  • As of Q1 2024, Petmed Express' Depreciation and Depletion stood at -$61000.0, which was down 10643.46% from $1.8 million recorded in Q4 2023.
  • In the past 5 years, Petmed Express' Depreciation and Depletion ranged from a high of $1.8 million in Q4 2023 and a low of -$61000.0 during Q1 2024
  • Over the past 5 years, Petmed Express' median Depreciation and Depletion value was $694000.0 (recorded in 2021), while the average stood at $840117.6.
  • Per our database at Business Quant, Petmed Express' Depreciation and Depletion soared by 12284.2% in 2023 and then plummeted by 10643.46% in 2024.
  • Over the past 5 years, Petmed Express' Depreciation and Depletion (Quarter) stood at $622000.0 in 2020, then grew by 14.15% to $710000.0 in 2021, then soared by 32.54% to $941000.0 in 2022, then surged by 88.1% to $1.8 million in 2023, then crashed by 103.45% to -$61000.0 in 2024.
  • Its Depreciation and Depletion was -$61000.0 in Q1 2024, compared to $1.8 million in Q4 2023 and $1.7 million in Q3 2023.